Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010–2016

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy(2022)10.1002/phar.2679Source: DataRank Database

Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010–2016 is a research paper published in Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2022). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 3.51)OA: hybridTopics (29)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Huijun An ORCID,RK Goyal ORCID,Mukaila A. Raji,Jodi B Segal ORCID,G. Caleb Alexander ORCID

Live enrichment

PubMed:35364622 PMC:PMC9302858 OpenAlex:https://openalex.org/W4224101831

National Institutes of Health

Grant: 1K01AG070329

National Institutes of Health

Grant: K24AG049036

NIA NIH HHS

Grant: K01 AG070329

NHLBI NIH HHS

Grant: T32 HL139426

Bristol-Myers Squibb

FWCI

3.51

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

hybridLicense: cc-by-nc

journalhttps://doi.org/10.1002/phar.2679

publisherhttps://doi.org/10.1002/phar.2679

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2679

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/phar.2679

publisherhttps://accpjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2679

Fields of Study

Venous Thromboembolism Diagnosis and ManagementAtrial Fibrillation Management and OutcomesChemotherapy-induced cardiotoxicity and mitigation

MeSH Terms

Administration, OralAgedAnticoagulantsAtrial FibrillationMedicareHemorrhageHumansNeoplasmsRetrospective StudiesUnited StatesWarfarinStroke

Keywords

MedicineAtrial fibrillationWarfarinHazard ratioInternal medicineOdds ratioConfidence intervalCancerStroke (engine)Logistic regressionAnticoagulantProportional hazards modelAnticoagulationDirect-acting Oral Anticoagulants

Sustainable Development Goals

SDG 0: Good health and well-being